Title and Organization:
Ann Lee-Karlon, PhD, is senior vice president at Genentech, a leading biotechnology company that discovers and develops medicines for patients with serious medical conditions. She leads Portfolio Management and Operations with oversight for more than 30 product development teams in the pipeline. Ann also heads business operations for the Genentech Research and Early Development division. Prior to joining Genentech, Ann was a leader in venture development at Eli Lilly. She has served as a senior biotech scientist in La Jolla and interned at UBS investment bank in London. Ann serves as president and board chair for the Genentech Patient Foundation, which provides medicines to patients who are uninsured or denied healthcare coverage. She was elected president and board chair for the Association of Women in Science (2014-2016), based in Washington, D.C. Ann holds an MBA from Stanford University, a BS in bioengineering from UC Berkeley, and a PhD in bioengineering from UC San Diego, where she was a National Science Foundation Fellow. She completed a postdoctoral fellowship at University College London as an NSF International Research Fellow. Ann was named one of the Remarkable Women of the University of California by the UC President's Office. She was elected Fellow of the American Institute for Medical and Biological Engineering. Ann is a Fellow of the inaugural class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.